Hart 

You are correct. I was in the front row less than 20 feet away and his exact words were " we missed it" although I am not sure there is a big difference.

Folks 

Sorry I forgot to include one of the important questions I asked. I asked Don about the new license agreement that would be ready by the end of 2016 and whether it was still on because we only had 2 weeks.

His reply:  " We missed it"  "But we are still in discussions"  I did not quiz him further nor did anybody else that I can recall. Seems like a really important issue so he got off easy on it. I would sure like to know who "we" is and what kind of discussions are on and if there is a new timeline.  

OK so this got me to thinking and inevitably I tend to go to pure wild speculation - its fun and I think relatively harmless and I don't mind being labelled as a Polyanna. Thats who I am - ever the optimist. I ask myself: Why the postponement of the AGM for over 60 days? I think everything was ready to go for Oct 15. Come on nothing is that difficult that they had to re-schedule for 2 months.   Why would the licensing agreement that was so confidentally told to be on before years end suddenly be " missed"  Why on my phone call to Sarah did she say she could not comment on matters material to the company? Methinks there is more going on behind the scenes than we know. PFE was mentioned several times in the meeting and they are on the acquisition trail. They just bought Medivation for $ 11B USD. I predict and here is my imitation of Narmac ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

$ 5.5B for RVX ( maybe Zenith included ) from PFE before June 30. Bet a case of Applteon Estates rum on it and ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, maybe Mr. Davenport would take the bet too.      

Torpedoman

Fouremms report was an excellent summary of what transpired at the AGM. It was a good meeting with attendance on par with recent years despite the very cold weather. My buddy and me were 25 minutes late due to traffic  

I will add a few comments from my notes and recollections. Most of the good info came from the Q & A. I atarted it off with asking where BetonMace stood. As reported many times the target is for 2400 patients. Don said they are about a third of the way to full enrollment - so around 800 patients. I asked if they know when there is a Mace event. He said yes but it is confidential. I was a little surprised at that because I thought they would be blinded to events.

The question was asked about a Nasdaq listing. Don said it would not happen in 2017 and not something they were pursuing. He said it was too costly, could take a long time and he was not sure it could even get them the attention they need. He said he felt their present approach presenting at high profile biotech events was making headway and when results from BETonMACE come in they will have all the attention they need.

I asked the question about the $ 120MM tax credits they have. He said it is actually up to $ 250MM now and that would be of great value particularly for USA BP repatriating profits residing in foreign countries. There was some further discussion around that subject and Don felt it would spur more investments in bioteh companies by BP. Pfizer alone has $ 68B sitting overseas

Later after the Q & A I asked Don about succession plans. He said that is in place.   

I asked if the "failure" of Assure to meet target has left a black mark on RVX as perceived by BP. He proceeded to go on a little bit about how difficult it was to deal with them and admitted that he was not dealing with the guys at the very top. He said they want to see top notch data from Phase 3 before striking.  

He mentioned that Aztra Seneca was not attending the big Biotech conference coming up and said "maybe somebody is buying them"  

I agree with Fouremm that Don seemed relaxed, confident and optimistic. The billion dollars of revenue in 2021 seems a stretch to me but I got my fingers crossed.   

Torpedoman

Will check my notes from the meeting and send a report this weekend 

Torpedoman

Bear

Thanks so much for clarifying the differences between these drugs. I'm always impressed by your knowledge.

Torpedoman 

Merry Chrsitmas and Happy New Year to all,

I just signed on. Had trouble getting registered until Agoracom got new software runnng.

I used to post on IV and SH as trt and torpedoman. Have been invested in RVX since Feb 2004 and seen all the gut-wrenching ups and downs. I have attended just about every AGM and will attned next week. Last week thought I would check out the venue at Mount Royal U which is a short distance from my office. The auditorium is huge much bigger than any previous sites.Maybe Don is expecting a whole bunch of CEOs, CFOs, CSOs, VPs and Presidents from BPs and maybe the Donald himself. Oh thats him. Right I forgot. More likely they got a good deal on the space and its walking distance from their office. I like it because I don't have to pay $ 30.00 for parking downtown.

Heh Fouremm I think you might attend We should introduce ourselves. I will likely be the only guy with a Yankees jacket on - love the Yanks, love NYC. 

I have some comments about a few things so here I go.

I got involved in wild speculation when they postponed the AGM but I had lots of company then. I had called Sarah ( shes a sweetheart ) and she got back to me. I asked her about the weather and whether something was hot at RVX. She quickly replied that she could not speak of things that were material to the company. Bingo and I harkened back to Jan 2007 when Don convened a meeting of shareholders at the Palliser hotel in Calgary. At that large meeting Don indicated he had an MOU with another company. Rumours were spreading that my old company ( lowly sales rep ) Pfizer was interested and supposedly the Pfizer corporate jet came into town a few weeks later ( never been confirmed to my knowledge ). I still believe Pfizer is interested but I think Don may have burned at least one bridge there.      

Don is a good guy and he has done a great job building a staff of great and brilliant people and  investors like Dart and Hepalink. I do worry about KD staying the course. I hope the loan will be extended. We should know more about the financial status after the meeting. I think Don either just turned 60 or is about to. He has many long time friends in Calgary who are shareholders. His family as well has shares. I am sure that Don does not want to disappoint any of them. With all the trials ( no pun intended ) and tribulations they have gone through and sitting at close to retirement age Don would surely like to see the final victory. 

This may be an unfair comment but I do not see anybody in the management team that could step into Dons shoes and do as good a job. I don't know whether there is a succession plan in place and I do not believe this question was ever addressed. I plan to ask the question next week.  

Bear, you posted about the Stephen Nichols assessment of the Assure and Sustain ad hoc analysis. Nichols is hardly a friend to RVX.  Very weak assessment  from a guy who abandoned RVX in that very dark moment in Chicago when the Assure results were announced. His actions bordered on traitorous then. He goes on to sing the praises of Mercks anacetrapib at that meeting further undermining RVX. Now its a dead product but he still has his hands in Mercks pockets.  

Re: the 7 to 8 year lead on epigenetic solutions to all things bad methinks the lead may be a lot shorter. The post about Viracta aquireing Phase 2 epigenetic drug from Chroma Therapeutics is interesting. This epigenetic candidate is VRx3996. Could the VRx stand for VerResX or possibly Reslevix or maybe Resverlogix? What brilliant deception! This would almost certainly  be the molecule that RVXs patent infringed on. It is being evaluated for cancer treament. Are we sure about that 7 year lead? Another question to ask at the AGM for Zenith.   

On the cardiovascular front we now have the the Jardiance and Victoza products showing significant MACE reduction and getting lots of attention. Thanks to Bear and bfw to bring those to our attention. If there is one thing we are really missing its attention from the market. Honestly I don't get it after all these years. It is so discouraging at times. Almost for sure there was interest back in 2007. Why not now? More questions to ask at the AGM  Bet on Mace looks like it will not finish until around mid 2018. It better hit a home run way out of the ballpark.

Torpedoman